Detalhe da pesquisa
1.
A primary care learning collaborative to improve office systems and clinical management of pediatric asthma.
J Asthma
; 58(3): 395-404, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838923
2.
Sparse modeling of spatial environmental variables associated with asthma.
J Biomed Inform
; 53: 320-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533437
3.
Estimating Wisconsin asthma prevalence using clinical electronic health records and public health data.
Am J Public Health
; 104(1): e65-73, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24228643
4.
Bronchiolitis recovery and the use of High Efficiency Particulate Air (HEPA) Filters (The BREATHE Study): study protocol for a multi-center, parallel, double-blind, randomized controlled clinical trial.
Trials
; 25(1): 197, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504367
5.
Pediatric asthma phenotypes.
Curr Opin Pediatr
; 24(3): 344-51, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22572759
6.
Facilitators and barriers to pediatric clinical trial recruitment and retention in rural and community settings: A scoping review of the literature.
Clin Transl Sci
; 15(4): 838-853, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35037409
7.
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial.
Vaccine
; 40(19): 2705-2713, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367069
8.
Capacity Building for a New Multicenter Network Within the ECHO IDeA States Pediatric Clinical Trials Network.
Front Pediatr
; 9: 679516, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34336738
9.
IDeA States Pediatric Clinical Trials Network for Underserved and Rural Communities.
Pediatrics
; 146(4)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32943534
10.
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713].
Vaccine
; 40(25): 3481, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534312